Correlation Between Plandai Biotech and A1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Plandai Biotech and A1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plandai Biotech and A1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Plandai Biotech and A1 Group, you can compare the effects of market volatilities on Plandai Biotech and A1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plandai Biotech with a short position of A1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plandai Biotech and A1.

Diversification Opportunities for Plandai Biotech and A1

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Plandai and A1 is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Plandai Biotech and A1 Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on A1 Group and Plandai Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plandai Biotech are associated (or correlated) with A1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of A1 Group has no effect on the direction of Plandai Biotech i.e., Plandai Biotech and A1 go up and down completely randomly.

Pair Corralation between Plandai Biotech and A1

Given the investment horizon of 90 days Plandai Biotech is expected to generate 3.15 times more return on investment than A1. However, Plandai Biotech is 3.15 times more volatile than A1 Group. It trades about 0.15 of its potential returns per unit of risk. A1 Group is currently generating about 0.04 per unit of risk. If you would invest  0.02  in Plandai Biotech on October 3, 2024 and sell it today you would lose (0.01) from holding Plandai Biotech or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Plandai Biotech  vs.  A1 Group

 Performance 
       Timeline  
Plandai Biotech 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.
A1 Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days A1 Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Plandai Biotech and A1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Plandai Biotech and A1

The main advantage of trading using opposite Plandai Biotech and A1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plandai Biotech position performs unexpectedly, A1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in A1 will offset losses from the drop in A1's long position.
The idea behind Plandai Biotech and A1 Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk